CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study 2026 Announcements . Clinical . News 24.04.2026
Appendix 3H — Notification of cessation of securities 2026 Announcements . Financial . News . Regulatory 17.04.2026
CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026 2026 Announcements . Corporate . News 15.04.2026
Download